Genprex Inc (GNPX)

Currency in USD
0.214
-0.008(-3.61%)
Closed·
After Hours
0.218+0.004(+1.96%)
·
GNPX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GNPX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2090.226
52 wk Range
0.2023.970
Key Statistics
Prev. Close
0.221
Open
0.22
Day's Range
0.209-0.226
52 wk Range
0.202-3.97
Volume
812.96K
Average Volume (3m)
2.06M
1-Year Change
-84.93%
Book Value / Share
0.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNPX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Genprex Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Genprex Inc Company Profile

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which uses lipid-based nanoparticles in a lipoplex form to deliver tumor suppressor gene-expressing plasmids to cancer cells. The company’s lead product candidate, Reqorsa gene therapy (quaratusugene ozeplasmid), for the treatment of non-small and small cell lung cancer. It is also developing diabetes gene therapy, a novel infusion process that uses an adeno-associated virus vector to deliver Pdx1 and MafA genes directly to the pancreatic duct; GPX-002 for Type 1 diabetes transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body’s immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has license agreement from the University of Pittsburgh of the Commonwealth System of Higher Education (University of Pittsburgh) multiple technologies relating to the development of a gene therapy product for both Type 1 and Type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Compare GNPX to Peers and Sector

Metrics to compare
GNPX
Peers
Sector
Relationship
P/E Ratio
−0.4x−3.1x−0.5x
PEG Ratio
0.00−0.110.00
Price/Book
1.8x2.2x2.6x
Price / LTM Sales
-150.6x3.3x
Upside (Analyst Target)
-196.4%43.4%
Fair Value Upside
Unlock4.0%7.1%Unlock

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.26 / -0.86
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GNPX Income Statement

People Also Watch

2.070
VOR
0.00%
18.23
SRPT
+1.50%
0.380
ADIL
-1.81%
2.56
INMB
-8.24%
0.547
WINT
-6.81%

FAQ

What Stock Exchange Does Genprex Trade On?

Genprex is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Genprex?

The stock symbol for Genprex is "GNPX."

What Is the Genprex Market Cap?

As of today, Genprex market cap is 7.09M.

What Is Genprex's Earnings Per Share (TTM)?

The Genprex EPS (TTM) is -2.58.

From a Technical Analysis Perspective, Is GNPX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genprex Stock Split?

Genprex has split 1 times.

How Many Employees Does Genprex Have?

Genprex has 15 employees.

What is the current trading status of Genprex (GNPX)?

As of 10 Aug 2025, Genprex (GNPX) is trading at a price of 0.21, with a previous close of 0.22. The stock has fluctuated within a day range of 0.21 to 0.23, while its 52-week range spans from 0.20 to 3.97.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.